Estrogens-Progestins Flashcards
What is the regulatory feedback on the HPG axis?
Estrogen neg feedback on LH FSH, at mid cycle has pos feedback on LH FSH. Surge in LH
Describe the biosynthetic sequence of steroidogenesis starting with cholesterol
Cholesterol in Theca cell converted to Pregnenolone - Progesterone - 17-OHP - Androstenedione - Testosterone -
Then Androstenedione and Testosterone travel to the Granulosa Cell and are converted to Estrone Estradiol Under stimulation of FSH
What are the primary physiological actions of Estrogen and Progesterone?
Estrogen: Neg/Pos feedback, Endometrial proliferation
Metabolic: Decrease LDL, Inc HDL
Bone: antiresportive
Liver: Inc Plasma Prots
Blood: inc exp of COAGULATION FACTORS
Development of female parts
Menstrual Cycle: regulates FOLLICULAR phase
Progesterone: feedback regulation, prep for implantation, decrease uterine contrac
Metabolic: Inc LDL, inc fat deposition
Glucose: increased fasting glucose
Development of female parts
Menstrual Cycle: regulator of LUTEAL phase
Uterus Smooth muscle: dec contraction, decrease prostaglandin production, maintain relaxin secretion
Cervical glands: more viscous
What are the MOA for synthetic and natural estrogens and progestins?
Estrogen:
- Natural (Estradiol):
- Synthetic (Ethinyl Estradiol, Mestranol):
- Non steroidal synthetic (Diethylstilbestrol):
Progesterone: Can use it in combination or alone (unlike estrogen)
- Nor-Compounds
- Medroxyprogesterone acetate (MPA)
Compare efficacy of different types of hormone birth control
Emergency contraceptive:
- Combined - failure rate of 25%
- Progestin only (plan b) - failure rate of 12%
What are the various routes of administration of hormonal contraceptives?
Oral: Combination or Progestin alone Injection: Combination or Progestin alone Implantable: Progestins alone Intrauterine Device: Progestins alone Transdermal: Combination Vaginal Ring: Combination
What are the adverse effects of each of the estrogen and progestin agonists?
Estrogen: Breast tenderness, Endometrial hyperplasia, Inc BLOOD COAGULATION;; Nausea, Cholestasis (From overactive LIVER!!), Migraine (Increased coag!!!), Ca? (endometrial and breast (invasive breast with combination therapy), bloating from loss of intravascular water
Progesterone:
- Breakthrough bleeding, change in vasc
- Impaired glucose tolerance
- Change in lipid metabolism
- Acne causing-19 Nor compounds
- Hirsutism - 19-Nor compounds
What are the key adverse effects of hormone birth control?
Mild: Nausea, Mastalgia, Breakthrough bleeding (from estrogen), Edema, Headache
Moderate: Breakthrough bleeding (from progesterone), Wt gain, acne, hirsutism (adjust to less androgenic 19-nor), vaginal infections, amenorrhea
Severe: Thromboembolic disease, MI, Cerebrovascular dz, GI, Depression, Cancer
HRT - Combination therapy: Invasive Breast Cancer (likely due to progestin)
HRT - Estrogen monotherapy: Endometrial cancer
Contraceptive therapy: Reduced risk of Ovarian/Endometrial Cancer
Cancer Mechanism: trophic effect of hormones/ROS
What are the therapeutic uses of estrogens and progestins?
Estrogen:
Use:
1. Hypogonadism
2. Hormone Replacement Therapy (bone dens, suppress hot flash, suppress urogenital atrophy) use less than 5 yrs
3. Contraception (suppress LH surge)
4. Acne Tx (may suppress steroidogenesis, inc SHBG production, causes less T to be developed and more to be bound in blood)
Progesterone:
Use:
1. Contraceptive: neg feedback, inc CERVICAL VISCOSITY
2. Hormone Replacement Therapy: decrease in endomet hyperplasia caused by estrogen
3. Dysmenorrhea - decrease endometrial mass - dec prostaglandin production
4. Endometriosis: inhibit proliferation of endometrial
Compare and contrast differences in
Combination Contraceptives:
Long Acting Contraceptives:
Post Coital Contraceptives:
Combination Contraceptives: suppress LH/FSH surge, alter cervical mucus, alter endometrium
Long Acting Contraceptives: Implantable, IUD, Injectable (Depo-Provera),
Post Coital Contraceptives: Plan B is popular, only 12% fail rate
Key outcomes of the Women’s Health Initiatives Studies
Estrogen PLUS Progesterone in healthy postmenopausal women:
INCREASED risk for: Coronary Heart disease, Stroke, Pulmonary Embolism, Invasive Breast Cancer
DECREASED risk for: Colorectal Cancer, Hip Fracture